CL2023001819A1 - Zearalenona conjugada para proteger contra la micotoxicosis. - Google Patents
Zearalenona conjugada para proteger contra la micotoxicosis.Info
- Publication number
- CL2023001819A1 CL2023001819A1 CL2023001819A CL2023001819A CL2023001819A1 CL 2023001819 A1 CL2023001819 A1 CL 2023001819A1 CL 2023001819 A CL2023001819 A CL 2023001819A CL 2023001819 A CL2023001819 A CL 2023001819A CL 2023001819 A1 CL2023001819 A1 CL 2023001819A1
- Authority
- CL
- Chile
- Prior art keywords
- mycotoxicosis
- zearalenone
- conjugated
- protect against
- protect
- Prior art date
Links
- 206010028520 Mycotoxicosis Diseases 0.000 title 1
- 231100000006 Mycotoxicosis Toxicity 0.000 title 1
- MBMQEIFVQACCCH-UHFFFAOYSA-N trans-Zearalenon Natural products O=C1OC(C)CCCC(=O)CCCC=CC2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-UHFFFAOYSA-N 0.000 title 1
- MBMQEIFVQACCCH-QBODLPLBSA-N zearalenone Chemical compound O=C1O[C@@H](C)CCCC(=O)CCC\C=C\C2=CC(O)=CC(O)=C21 MBMQEIFVQACCCH-QBODLPLBSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Beans For Foods Or Fodder (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Insulated Conductors (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20216328 | 2020-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023001819A1 true CL2023001819A1 (es) | 2024-03-08 |
Family
ID=73856714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023001819A CL2023001819A1 (es) | 2020-12-22 | 2023-06-19 | Zearalenona conjugada para proteger contra la micotoxicosis. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240024496A1 (es) |
| EP (1) | EP4267187A1 (es) |
| JP (1) | JP2023554137A (es) |
| CN (1) | CN116710144A (es) |
| AU (1) | AU2021406283A1 (es) |
| CA (1) | CA3202786A1 (es) |
| CL (1) | CL2023001819A1 (es) |
| MX (1) | MX2023007536A (es) |
| WO (1) | WO2022136343A1 (es) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106397597A (zh) * | 2016-09-14 | 2017-02-15 | 湖南沙博安科技有限责任公司 | 一种抗f2卵黄抗体的制备方法 |
-
2021
- 2021-12-21 AU AU2021406283A patent/AU2021406283A1/en active Pending
- 2021-12-21 US US18/257,415 patent/US20240024496A1/en active Pending
- 2021-12-21 CA CA3202786A patent/CA3202786A1/en active Pending
- 2021-12-21 CN CN202180086848.9A patent/CN116710144A/zh active Pending
- 2021-12-21 EP EP21840042.2A patent/EP4267187A1/en active Pending
- 2021-12-21 JP JP2023537665A patent/JP2023554137A/ja active Pending
- 2021-12-21 WO PCT/EP2021/086945 patent/WO2022136343A1/en active Application Filing
- 2021-12-21 MX MX2023007536A patent/MX2023007536A/es unknown
-
2023
- 2023-06-19 CL CL2023001819A patent/CL2023001819A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20240024496A1 (en) | 2024-01-25 |
| CA3202786A1 (en) | 2022-06-30 |
| AU2021406283A1 (en) | 2023-06-22 |
| EP4267187A1 (en) | 2023-11-01 |
| MX2023007536A (es) | 2023-07-10 |
| WO2022136343A1 (en) | 2022-06-30 |
| JP2023554137A (ja) | 2023-12-26 |
| CN116710144A (zh) | 2023-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018003207A1 (es) | Procedimientos para tratar cancer de piel a traves de la administración de un inhibidor pd-1. | |
| MA42599A (fr) | Dérivés de triazole, leurs intermédiaires et leur utilisation comme fongicides | |
| BR112015030543B8 (pt) | Preparação para aplicação tópica para o tratamento da pele e infecções da mucosa | |
| CL2011002595A1 (es) | Uso de una combinacion de un agente anticancerigeno y un antioxidante para tratar el cancer; y compicicion farmaceutica que comprende dicha combinacion. | |
| WO2013120829A3 (de) | Stabile wasser in öl emulsionen mit spreitfähigen ölen | |
| CL2015000434A1 (es) | Metodo para el tratamiento, prevencion o disminucion de la severidad de una condicion o trastorno no neoplasico de la piel que comprende administrar un compuesto derivado de retinoides; composicion dermica que comprende los derivados de retinoide. | |
| BR112017023041A2 (pt) | emulsões tópicas de filtro solar. | |
| AR096402A1 (es) | Medicamento de metformina y dihidroquercetina | |
| CO2021003103A2 (es) | Composiciones oleaginosas tópicas | |
| CL2020001273A1 (es) | Emulsiones para el tratamiento tópico de infecciones dérmicas y de infecciones de mucosas. | |
| UA93466C2 (uk) | Сигаретний папір з низькою здатністю до займання | |
| CL2023001819A1 (es) | Zearalenona conjugada para proteger contra la micotoxicosis. | |
| CL2023001843A1 (es) | Fumonisina conjugada para proteger contra la micotoxicosis. | |
| CL2014001596A1 (es) | Un protector para una bomba rotativa, la cual tiene un cuerpo principal, una carcasa de impulsor, un eje de trasmision, una disposicion de sello, el protector proporciona acceso para ajustar la disposicion de sello, pero obstruye el acceso al eje de transmision; y una bomba rotativa. | |
| CL2023001842A1 (es) | Aflatoxina b conjugada para proteger contra la micotoxicosis. | |
| EP3870557A4 (en) | SENSITIZED, SAFE TO PRODUCE AND ECO-FRIENDLY EXPLOSIVE COMPOSITION | |
| ES2973249T3 (es) | Composición que comprende cepa de Agathobaculum sp. como ingrediente efectivo para la prevención, alivio o tratamiento del trastorno del espectro autista | |
| CL2023001817A1 (es) | Toxina t-2 conjugada para proteger contra la mitocoxitosis. | |
| AR078942A1 (es) | Composicion que comprende agente para expulsar parasitos | |
| AR103484A1 (es) | Triptólido y sus derivados en el tratamiento de tumores y patologías precancerosas de la piel | |
| GB201505938D0 (en) | Compositions comprising C0-Q10, krill oil and vitamin D | |
| ES1261399Y (es) | Dispositivo de protección contra inundaciones. | |
| UA45069S (uk) | 1. комбінований головний убір «балаклава» | |
| ES1284981Y (es) | Dispositivo protector para árboles. | |
| ES1282234Y (es) | Consignas inteligentes. |